Arab News highlighted Saudi Arabia’s plans to announce major biotechnology and pharmaceutical partnerships during the Global Health Exhibition in Riyadh. The initiative forms part of the broader Vision 2030 transformation, a strategy that is rapidly reshaping the healthcare and life sciences landscape across the entire Middle East region. The royal families, the governments, investors, and healthcare leaders are accelerating efforts to strengthen health systems, expand pharma

Ethics Is Now a Condition for Doing Business Full article by the Times: https://www.thetimes.com/business/companies-markets/article/health-overtakes-climate-change-for-esg-investors-337j6kxb9?utm_source=chatgpt.com Global Impact Ambassadors: Over the past week, several developments across ESG and CSR, healthcare, and global markets have pointed to a shift that has been building for years, but is now becoming undeniable. Ethical business is no longer a positioning strategy. It

Ethical business is not a marketing strategy.It is not a branding exercise.And it is certainly not a “nice to have” once profitability is secured. Recent commentary in the business press reinforces what should already be obvious: companies that treat ethics as infrastructure, rather than decoration, outperform over time. Culture, governance, transparency, and accountability are not soft concepts. They are risk management. They are brand protection. They are long-term value cr

The Supreme Court of India recently made a clear and important observation: patients and the public must have access to proper remedies when pharmaceutical companies engage in unethical practices. The Court questioned whether voluntary industry codes are sufficient and pointed to the need for stronger, enforceable mechanisms rather than merely signal good intent. This is not an anti-pharma argument. It is a pro-ethics, pro-patient, and pro-trust one. Unethical behaviour in ou